Læknablaðið - 15.04.1998, Blaðsíða 94
The Novo Nordisk
Foundation
Brogðrdsvej 70
Postbox 71
2820 Gentofte
Tel: +45 4443 9031
Fox +45 4443 9098
CALL FOR PROPOSALS
ascular Biology
Complications in
of
Diabetes
The Novo Nordisk Foundation hereby invites applications for a
Scandinavian Research Consortium ('Centre Without Walls') within
Vascular Biology of Complications in Diabetes
The background for selection of this topic is the need for basic
research in a field that has great implications for the individual
patient as well as for public health care expenditure.
The Foundation has decided to fund a Consortium of internatio-
nally highly qualified research groups that jointly address funda-
mental aspects of vascular disease in diabetes.
Contad to clinical research is considered of importance.
The Foundation will support the selected Consortium with a total
of 100 mill. DKK
in the following way: up to 10 mill. DKK per year for a period of up
to 10 years provided progress of the work is satisfadory. The amount
refleds realistic costs of a coherent set of ambitious projeds and
the long term nature of such research.
It is envisaged that the Consortium will consist of three to five
well-established research groups that jointly cover a range of rel-
evant areas within the field. The scientific head of one of the re-
search groups must be identified as 'Lead Investigator' and will
have the responsibility for reporting to the Foundation on progress
in research, as well as in matters of management and economy.
Even though the Consortium must have its base in Scandinavia,
collaboration with important research groups outside Scandinavia
should be considered.
Proposals seleded for final evaluation will be subjected to an in-
ternational Peer Review and to site visits.
Applications must be received by the Foundation no later
than June 4, 1998. Detailed information and application forms
can be requested from the Novo Nordisk Foundation, Brogárdsvej
70, Postboks 71, DK 2820 Gentofte, e-mail:nnfond@novo.dk
Information and application forms are available on the Internet:
http://www.novonordiskfonden.dk
The Novo Nordisk Foundation is o self-governing, profit-making foundation with two
main purposes: to provide a stable foundation for Novo Nordisk A/S by holding a
voting majoríty ofstock in the company, and to support research outside Novo Nordisk
A/S (mainly in the biomedical sciences). Funds for the support of research are derived
prímaríly from dividends ofthe Foundation's holding ofshares in the company. Projects
to be supported are selected by independent, academic review committees.